Vaccine, immunity no help in HIV

Initial analysis confirmed that an HIV vaccine from a linkurl:halted;http://www.the-scientist.com/blog/display/53633/ trial does not prevent or quell infection, according to data presented today at the HIV Vaccine Trials Network meeting. According to the linkurl:press release;http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20071107005139&newsLang=en from Merck, the investigational vaccine (V520) was not shown to be effective at preventing infection or reduc

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Initial analysis confirmed that an HIV vaccine from a linkurl:halted;http://www.the-scientist.com/blog/display/53633/ trial does not prevent or quell infection, according to data presented today at the HIV Vaccine Trials Network meeting. According to the linkurl:press release;http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20071107005139&newsLang=en from Merck, the investigational vaccine (V520) was not shown to be effective at preventing infection or reducing viral load in patients who became infected during the course of the trial. This analysis confirms the earlier findings on about half of the halted trial patients, released September 21. Other preliminary analysis indicated that for patients with a pre-existing immunity to the vector carrying the HIV genes as a vaccine there were actually more cases of infection than with placebo. Anthony Fauci, director of the National Institutes of Allergy and Infectious Disease, said in a linkurl:statement;http://www3.niaid.nih.gov/about/directors/news/step_11707.htm that the data show no clear reason why the vaccine would not be effective and that these initial results were both "disappointing and puzzling."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital
Concept illustration of acoustic waves and ripples.

Comparing Analytical Solutions for High-Throughput Drug Discovery

sciex

Products

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome

Magid Haddouchi, PhD, CCO

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer